"The potency of RTK inhibition by BJ-1301 was lower than that of sunitinib (a multi-RTK inhibitor) but the inhibition of downstream signaling pathways (e.g. ROS generation) and subsequent biological changes (e.g. NOX2 induction) by BJ-1301 was superior"xsd:string